ReviewExpert opinion on therapeutic targets2008

Targeting glycogen synthase kinase-3 (GSK-3) in the treatment of Type 2 diabetes.

Katrina MacAulay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.